Showing results (1031-1040 of 3,150) with videos related to
Sort By:
Pageof 315
Neuro-Oncology|May 23, 2017
Citation classics in neuro-oncology: assessment of historical trends and scientific progressLaureen D Hachem, Alireza Mansouri, Kyle Juraschka, et al.Neuro-Oncology|May 26, 2017
Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesisAntony Prabhu, Pravin Kesarwani, Shiva Kant, et al.Neuro-Oncology|May 26, 2017
The interplay between metabolic remodeling and immune regulation in glioblastomaPravin Kesarwani, Shiva Kant, Antony Prabhu, et al.Neuro-Oncology|June 25, 2017
Prognostic awareness, prognostic communication, and cognitive function in patients with malignant gliomaEli L Diamond, Holly G Prigerson, Denise C Correa, et al.Neuro-Oncology|June 3, 2017
Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplificationJuan Manuel Sepúlveda-Sánchez, María Ángeles Vaz, Carmen Balañá, et al.Neuro-Oncology|June 3, 2017
Adult IDH wild-type lower-grade gliomas should be further stratifiedAbudumijit Aibaidula, Aden Ka-Yin Chan, Zhifeng Shi, et al.Neuro-Oncology|June 3, 2017
miR miR on the wall, who's the most malignant medulloblastoma miR of them all?Xin Wang, Borja L Holgado, Vijay Ramaswamy, et al.Neuro-Oncology|June 13, 2017
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastomaMark W Kieran, Julia Chisholm, Michela Casanova, et al.Neuro-Oncology|April 29, 2017
Significance of low mTORC1 activity in defining the characteristics of brain tumor stem cellsYi-Peng Han, Atsushi Enomoto, Yukihiro Shiraki, et al.Neuro-Oncology|April 29, 2017
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteriaLakshmi Nayak, Lisa M DeAngelis, Alba A Brandes, et al.Pageof 315